Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
about
Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cellsDose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer CellsG protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.In vivo monitoring of the antiangiogenic effect of neurotensin receptor-mediated radiotherapy by small-animal positron emission tomography: a pilot study.Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancerPeptides and peptide hormones for molecular imaging and disease diagnosisInduced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cellsCrosstalk between insulin receptor and G protein-coupled receptor signaling systems leads to Ca²+ oscillations in pancreatic cancer PANC-1 cells.Role of protein kinase D signaling in pancreatic cancerReceptor trafficking via the perinuclear recycling compartment accompanied by cell division is necessary for permanent neurotensin cell sensitization and leads to chronic mitogen-activated protein kinase activation.Molecular imaging of gene expression and protein function in vivo with PET and SPECT.Regulatory peptide receptors in human hepatocellular carcinomas.Neurotensin and its receptors in the control of glucose homeostasis.The role of neurotensin in central nervous system pathophysiology: what is the evidence?Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.Theranostic Value of Multimers: Lessons Learned from Trimerization of Neurotensin Receptor Ligands and Other Targeting Vectors.Radiometallated peptides for molecular imaging and targeted therapy.Rationale for the use of radiolabelled peptides in diagnosis and therapy.Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway.Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasiaEvaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.New Neurotensin analogue radiolabeled by (99m) Technetium as a potential agent for tumor identification.A (99m) Tc-tricine-HYNIC-labeled peptide targeting the neurotensin receptor for single-photon imaging in malignant tumors.Neurotensin receptors in pancreatic ductal carcinomas.Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.Gut peptide receptor expression in human pancreatic cancers.Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists.KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors.Structure-Activity Relationship Studies of Amino Acid Substitutions in Radiolabeled Neurotensin Conjugates.Flow-Assisted Synthesis: A Key Fragment of SR 142948AStereoselective Synthesis of β-(5-Arylthiazolyl) α-Amino Acids and Use in Neurotensin Analogues
P2860
Q24654005-4363BC7F-E04F-4D87-A0B0-C6B33368D167Q28542653-D16ABB0E-9471-465F-839A-352AFD648819Q31809911-D6DF7D81-655E-4DE1-98EA-A3432A342FC1Q33584733-721A867A-8E00-4813-9136-E2BE00D2E6D3Q33820455-E8D598BA-62E9-4FE5-B75E-55229B81BA38Q33846924-527D7356-0E87-4E53-AF9C-C096F9729E01Q33923820-A9A7CD12-394C-481F-A138-B3FB6BCD6602Q34188673-773A831E-335F-4C37-810B-2420FD517B30Q34279846-4C229D1B-3C90-40C1-85AF-4C62A1F6FF72Q34286857-31FC88EC-164E-4129-85DB-725751AA8F53Q34918519-F9713B14-321F-4182-A85E-FB828F1A43F3Q35357724-77DA6362-CA89-4BCE-A5A8-1C44FC7B78AAQ36449538-9C70FBF6-B212-47D3-B2C4-DE6BD2F7EDD9Q36544566-E3B89FF4-11B4-484E-BDD5-3F40C4BFF198Q37365603-D8A99782-0608-4633-9DE6-87CC5F172BE6Q37399121-78C86CAE-05C0-4325-BC71-932723213A81Q37573308-2EE70C6F-2DA5-407F-AB44-5FE2E56B3731Q37731332-F4AFFB2D-02CA-4CDE-8641-B03C10B3A77AQ37847064-64FD663E-99AF-439F-81A7-F8D44D482C56Q37990410-44C96E29-465B-4A6F-B3F5-25B005E5C4CFQ38248621-3A53E0F9-01BE-46A5-A976-6470D6BD1987Q38596500-D911D019-0101-4B94-86F7-43FD9F906ECCQ38680000-8530BDD0-0E5A-49F2-856E-351459E03498Q38694727-F7236414-D2F5-47B5-8610-AF9AAED49CE2Q39036960-DA4E08F1-6FC0-4C93-8AAB-8BA905617476Q39336194-115F5F09-BC80-4C24-AAD8-3CC3197577AEQ39400663-4BE54F50-0C81-499B-89C9-6DE40C6F0756Q40879057-3FC1E1A8-31B6-4D54-9BDC-1E6AEC79065DQ44391310-2A389F93-C93A-4F71-BB7D-398070D6EBF2Q46471150-91B18181-542F-4D4D-AB5C-FE00D227A00AQ48346415-044C675C-FED5-440A-B479-BD724EE03337Q52901225-50489376-E184-4979-9513-087B8F68FDDFQ57816227-68FA892B-F421-442B-BC37-10896AB481D8Q58099616-E94AADF3-DC8D-45FA-9B4B-EAA20D0050AF
P2860
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
@ast
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
@en
type
label
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
@ast
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
@en
prefLabel
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
@ast
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma.
@en
P2093
P2860
P304
P356
10.1136/GUT.42.4.546
P407
P577
1998-04-01T00:00:00Z